Nexien BioPharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 55.07M and sold 30.46M NXEN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 55.07M shares
Sell 30.46M shares
92% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 23, 2024
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 1 000 000
Value: $0
May 23, 2024
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 2 000 000
Value: $0
May 23, 2024
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 2 000 000
Value: $0
May 23, 2024
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 1 000 000
Value: $0
Oct 31, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Oct 31, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Oct 31, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Oct 31, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Jul 25, 2023
Buy
Common Stock
A-Award
Goldfarb Robert I
Chief Operating Officer
C-Suite Officer 250 000
Value: $0
Jul 25, 2023
Buy
Common Stock
A-Award
Goldfarb Robert I
Chief Operating Officer
C-Suite Officer 250 000
Value: $0
Jul 25, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Jul 25, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Jul 25, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Jul 25, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Apr 01, 2023
Buy
Common Stock
A-Award
Goldfarb Robert I
Chief Operating Officer
C-Suite Officer 250 000
Value: $0
Apr 01, 2023
Buy
Common Stock
A-Award
Goldfarb Robert I
Chief Operating Officer
C-Suite Officer 250 000
Value: $0
Apr 01, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Apr 01, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Apr 01, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Apr 01, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Jan 17, 2023
Buy
Common Stock
A-Award
Goldfarb Robert I
Chief Operating Officer
C-Suite Officer 250 000
Value: $0
Jan 17, 2023
Buy
Common Stock
A-Award
Goldfarb Robert I
Chief Operating Officer
C-Suite Officer 250 000
Value: $0
Jan 17, 2023
Buy
Common stock
A-Award
Wasoff Evan L
Chief Financial Officer
C-Suite Officer 250 000
Value: $0
Jan 17, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0
Jan 17, 2023
Buy
Common Stock
A-Award
Greenberg Richard S
Chief Executive Officer
CEO / President 250 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NEXIEN BIOPHARMA, INC.
Nexien BioPharma
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Color...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE